http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63612555 2013 France summary of product characteristics topotecan hydrochloride powders topotecan
--- http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68867734 2013 France summary of product characteristics topotecan topotecan hydrochloride
--- http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68531000 2013 France summary of product characteristics topotecan topotecan hydrochloride powders
--- http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66352155 2012 France summary of product characteristics package leaflet topotecan hydrochloride topotecan
--- http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67286943 2012 France summary of product characteristics package leaflet topotecan topotecan hydrochloride
--- http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65275325 2012 France summary of product characteristics package leaflet topotecan topotecan hydrochloride
--- http://www.has-sante.fr/portail/display.jsp?id=c_538692 2007 false France French topotecan hydrochloride cisplatin Stage IVB Cervical Cancer AJCC v6 and v7 Recurrent Cervical Carcinoma antineoplastic agents topotecan infusions, parenteral uterine cervical neoplasms antineoplastic combined chemotherapy protocols carcinoma recurrence treatment outcome topotecan evaluation of the transparency committee
--- http://www.has-sante.fr/portail/display.jsp?id=c_401027 2006 false France French topotecan hydrochloride Small cell lung cancer recurrent antineoplastic agents enzyme inhibitors topotecan infusions, intravenous neoplasm recurrence, local treatment outcome topotecan small cell lung carcinoma evaluation of the transparency committee